FTC Wins Around $73M From Defendants Behind ‘Risk-Free’ Skin-Care Trials
This article was originally published in The Rose Sheet
Executive Summary
A California district court has imposed injunctions and monetary penalties on roughly 30 companies and individuals that cooperated to sell AuraVie, Dellure and LéOR Skincare offerings, among others, via deceptive “risk-free” trial plans, according to FTC. The agency says it will continue to go after negative-option billing schemes that charge consumers for recurring product shipments without their express consent.